510 related articles for article (PubMed ID: 22786457)
1. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review.
Fischer B; Argento E
Pain Physician; 2012 Jul; 15(3 Suppl):ES191-203. PubMed ID: 22786457
[TBL] [Abstract][Full Text] [Related]
2. Prescription Opioid Use, Harms and Interventions in Canada: A Review Update of New Developments and Findings since 2010.
Murphy Y; Goldner EM; Fischer B
Pain Physician; 2015; 18(4):E605-14. PubMed ID: 26218951
[TBL] [Abstract][Full Text] [Related]
3. Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: an update 5 years later.
Fischer B; Gooch J; Goldman B; Kurdyak P; Rehm J
Can J Public Health; 2014 Apr; 105(2):e146-9. PubMed ID: 24886852
[TBL] [Abstract][Full Text] [Related]
4. Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world?
Fischer B; Keates A; Bühringer G; Reimer J; Rehm J
Addiction; 2014 Feb; 109(2):177-81. PubMed ID: 23692335
[TBL] [Abstract][Full Text] [Related]
5. Reductions in non-medical prescription opioid use among adults in Ontario, Canada: are recent policy interventions working?
Fischer B; Ialomiteanu A; Kurdyak P; Mann RE; Rehm J
Subst Abuse Treat Prev Policy; 2013 Feb; 8():7. PubMed ID: 23406368
[TBL] [Abstract][Full Text] [Related]
6. Harms of prescription opioid use in the United States.
Imtiaz S; Shield KD; Fischer B; Rehm J
Subst Abuse Treat Prev Policy; 2014 Oct; 9():43. PubMed ID: 25352167
[TBL] [Abstract][Full Text] [Related]
7. Assessing the prevalence of nonmedical prescription opioid use in the general Canadian population: methodological issues and questions.
Fischer B; Nakamura N; Ialomiteanu A; Boak A; Rehm J
Can J Psychiatry; 2010 Sep; 55(9):606-9. PubMed ID: 20840808
[TBL] [Abstract][Full Text] [Related]
8. Illicit drug use and harms, and related interventions and policy in Canada: A narrative review of select key indicators and developments since 2000.
Fischer B; Murphy Y; Rudzinski K; MacPherson D
Int J Drug Policy; 2016 Jan; 27():23-35. PubMed ID: 26359046
[TBL] [Abstract][Full Text] [Related]
9. Prescription opioid prescribing, use/misuse, harms and treatment among Aboriginal people in Canada: a narrative review of available data and indicators.
Russell C; Firestone M; Kelly L; Mushquash C; Fischer B
Rural Remote Health; 2016; 16(4):3974. PubMed ID: 27871180
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of pain among nonmedical prescription opioid users in substance use treatment populations: systematic review and meta-analyses.
Lusted A; Roerecke M; Goldner E; Rehm J; Fischer B
Pain Physician; 2013; 16(6):E671-84. PubMed ID: 24284850
[TBL] [Abstract][Full Text] [Related]
11. Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review.
Amari E; Rehm J; Goldner E; Fischer B
Can J Psychiatry; 2011 Aug; 56(8):495-502. PubMed ID: 21878161
[TBL] [Abstract][Full Text] [Related]
12. Patterns, Changes, and Trends in Prescription Opioid Dispensing in Canada, 2005-2016.
Fischer B; Jones W; Vojtila L; Kurdyak P
Pain Physician; 2018 May; 21(3):219-228. PubMed ID: 29871366
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids.
Moride Y; Lemieux-Uresandi D; Castillon G; de Moura CS; Pilote L; Faure M; Bernartsky S
Pain Physician; 2019 May; 22(3):229-240. PubMed ID: 31151331
[TBL] [Abstract][Full Text] [Related]
14. Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009.
Fischer B; Nakamura N; Rush B; Rehm J; Urbanoski K
Drug Alcohol Depend; 2010 Jun; 109(1-3):257-60. PubMed ID: 20197216
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of mental health and pain symptoms in general population samples reporting nonmedical use of prescription opioids: a systematic review and meta-analysis.
Fischer B; Lusted A; Roerecke M; Taylor B; Rehm J
J Pain; 2012 Nov; 13(11):1029-44. PubMed ID: 23040158
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses.
Goldner EM; Lusted A; Roerecke M; Rehm J; Fischer B
Addict Behav; 2014 Mar; 39(3):520-31. PubMed ID: 24333033
[TBL] [Abstract][Full Text] [Related]
17. Revisiting the 'paradigm shift' in opioid use: Developments and implications 10 years later.
Fischer B; Rehm J
Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S199-S202. PubMed ID: 28334467
[TBL] [Abstract][Full Text] [Related]
18. How many people in Canada use prescription opioids non-medically in general and street drug using populations?
Popova S; Patra J; Mohapatra S; Fischer B; Rehm J
Can J Public Health; 2009; 100(2):104-8. PubMed ID: 19839284
[TBL] [Abstract][Full Text] [Related]
19. Non-medical use of prescription opioids and public health in Canada: an urgent call for research and interventions development.
Fischer B; Rehm J; Goldman B; Popova S
Can J Public Health; 2008; 99(3):182-4. PubMed ID: 18615937
[TBL] [Abstract][Full Text] [Related]
20. Chronic pain and opioid misuse: a review of reviews.
Voon P; Karamouzian M; Kerr T
Subst Abuse Treat Prev Policy; 2017 Aug; 12(1):36. PubMed ID: 28810899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
